Bronchiolitis obliterans may result from lung injury caused by a variety of different chemicals and respiratory infections. Inhaled chemicals known to irritate the lungs and lead to the condition include chlorine; ammonia; oxides of nitrogen or sulfur dioxide; welding fumes; or food flavoring fumes (such as diacetyl). Respiratory infections caused by a respiratory syncytial virus, adenovirus, or Mycoplasma pneumonia have been linked with the condition.
This report contains market size and forecasts of Bronchiolitis Obliterans Syndrome in Global, including the following market information:
Global Bronchiolitis Obliterans Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bronchiolitis Obliterans Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inhalation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bronchiolitis Obliterans Syndrome include Breath Therapeutics, Genentech, Incyte Corporation, Mereo BioPharma, Altavant Sciences and Koutif Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bronchiolitis Obliterans Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bronchiolitis Obliterans Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bronchiolitis Obliterans Syndrome Market Segment Percentages, by Type, 2021 (%)
Inhalation
Oral
Global Bronchiolitis Obliterans Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bronchiolitis Obliterans Syndrome Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Bronchiolitis Obliterans Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bronchiolitis Obliterans Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bronchiolitis Obliterans Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bronchiolitis Obliterans Syndrome revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Breath Therapeutics
Genentech
Incyte Corporation
Mereo BioPharma
Altavant Sciences
Koutif Therapeutics